Trials / Conditions / Concurrent Chemoradiotherapy

Concurrent Chemoradiotherapy

13 registered clinical trials studyying Concurrent Chemoradiotherapy — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advance NCT07086456	Sun Yat-sen University	Phase 2
Recruiting	Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunot NCT06734702	Sun Yat-sen University	Phase 3
Recruiting	Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC NCT06288373	Tongji Hospital	Phase 2 / Phase 3
Active Not Recruiting	Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous NCT06342167	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2
Completed	The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients NCT05944809	JIANYANG WANG	Phase 2
Active Not Recruiting	Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Canc NCT05621707	Shanghai Chest Hospital	Phase 2
Recruiting	Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer NCT06391190	RenJi Hospital	Phase 1 / Phase 2
Recruiting	the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer NCT06378840	RenJi Hospital	—
Unknown	NAC Followed by RH for the Treatment of LACC NCT03963882	Lei Li	Phase 2
Unknown	Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma NCT03908372	Chinese Academy of Medical Sciences	Phase 2 / Phase 3
Unknown	Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer NCT03579004	Mona Frolova	Phase 2
Unknown	Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer NCT01180166	Chinese Academy of Medical Sciences	Phase 2
Completed	CCRT for Esophageal Cancer. NCT02607982	Hangzhou Cancer Hospital	Phase 2